Cargando…
Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4
INTRODUCTION: HIV-1 persists in resting CD4(+) T-cells despite antiretroviral therapy (ART). Determining the cell surface markers that enrich for genetically-intact HIV-1 genomes is vital in developing targeted curative strategies. Previous studies have found that HIV-1 proviral DNA is enriched in C...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909745/ https://www.ncbi.nlm.nih.gov/pubmed/36776833 http://dx.doi.org/10.3389/fimmu.2023.1064346 |
_version_ | 1784884639781879808 |
---|---|
author | Fisher, Katie Schlub, Timothy E. Boyer, Zoe Rasmussen, Thomas A. Rhodes, Ajantha Hoh, Rebecca Hecht, Frederick M. Deeks, Steven G. Lewin, Sharon R. Palmer, Sarah |
author_facet | Fisher, Katie Schlub, Timothy E. Boyer, Zoe Rasmussen, Thomas A. Rhodes, Ajantha Hoh, Rebecca Hecht, Frederick M. Deeks, Steven G. Lewin, Sharon R. Palmer, Sarah |
author_sort | Fisher, Katie |
collection | PubMed |
description | INTRODUCTION: HIV-1 persists in resting CD4(+) T-cells despite antiretroviral therapy (ART). Determining the cell surface markers that enrich for genetically-intact HIV-1 genomes is vital in developing targeted curative strategies. Previous studies have found that HIV-1 proviral DNA is enriched in CD4(+) T-cells expressing the immune checkpoint markers programmed cell death protein-1 (PD-1) or cytotoxic T-lymphocyte associated protein-4 (CTLA-4). There has also been some success in blocking these markers in an effort to reverse HIV-1 latency. However, it remains unclear whether cells expressing PD-1 and/or CTLA-4 are enriched for genetically-intact, and potentially replication-competent, HIV-1 genomes. METHODS: We obtained peripheral blood from 16 HIV-1-infected participants, and paired lymph node from four of these participants, during effective ART. Memory CD4(+) T-cells from either site were sorted into four populations: PD-1(-)CTLA-4(-) (double negative, DN), PD-1(+)CTLA-4(-) (PD-1(+)), PD-1(-)CTLA-4(+) (CTLA-4(+)) and PD-1(+)CTLA-4(+) (double positive, DP). We performed an exploratory study using the full-length individual proviral sequencing (FLIPS) assay to identify genetically-intact and defective genomes from each subset, as well as HIV-1 genomes with specific intact open reading frames (ORFs). RESULTS AND DISCUSSION: In peripheral blood, we observed that proviruses found within PD-1(+) cells are more likely to have intact ORFs for genes such as tat, rev and nef compared to DN, CTLA-4(+) and DP cells, all of which may contribute to HIV-1 persistence. Conversely, we observed that CTLA-4 expression is a marker for cells harbouring HIV-1 provirus that is more likely to be defective, containing low levels of these intact ORFs. In the lymph node, we found evidence that CTLA-4(+) cells contain lower levels of HIV-1 provirus compared to the other cell subsets. Importantly, however, we observed significant participant variation in the enrichment of HIV-1 proviruses with intact genomes or specific intact ORFs across these memory CD4(+) T-cell subsets, and therefore consideration of additional cellular markers will likely be needed to consistently identify cells harbouring latent, and potentially replication-competent, HIV-1. |
format | Online Article Text |
id | pubmed-9909745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99097452023-02-10 Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4 Fisher, Katie Schlub, Timothy E. Boyer, Zoe Rasmussen, Thomas A. Rhodes, Ajantha Hoh, Rebecca Hecht, Frederick M. Deeks, Steven G. Lewin, Sharon R. Palmer, Sarah Front Immunol Immunology INTRODUCTION: HIV-1 persists in resting CD4(+) T-cells despite antiretroviral therapy (ART). Determining the cell surface markers that enrich for genetically-intact HIV-1 genomes is vital in developing targeted curative strategies. Previous studies have found that HIV-1 proviral DNA is enriched in CD4(+) T-cells expressing the immune checkpoint markers programmed cell death protein-1 (PD-1) or cytotoxic T-lymphocyte associated protein-4 (CTLA-4). There has also been some success in blocking these markers in an effort to reverse HIV-1 latency. However, it remains unclear whether cells expressing PD-1 and/or CTLA-4 are enriched for genetically-intact, and potentially replication-competent, HIV-1 genomes. METHODS: We obtained peripheral blood from 16 HIV-1-infected participants, and paired lymph node from four of these participants, during effective ART. Memory CD4(+) T-cells from either site were sorted into four populations: PD-1(-)CTLA-4(-) (double negative, DN), PD-1(+)CTLA-4(-) (PD-1(+)), PD-1(-)CTLA-4(+) (CTLA-4(+)) and PD-1(+)CTLA-4(+) (double positive, DP). We performed an exploratory study using the full-length individual proviral sequencing (FLIPS) assay to identify genetically-intact and defective genomes from each subset, as well as HIV-1 genomes with specific intact open reading frames (ORFs). RESULTS AND DISCUSSION: In peripheral blood, we observed that proviruses found within PD-1(+) cells are more likely to have intact ORFs for genes such as tat, rev and nef compared to DN, CTLA-4(+) and DP cells, all of which may contribute to HIV-1 persistence. Conversely, we observed that CTLA-4 expression is a marker for cells harbouring HIV-1 provirus that is more likely to be defective, containing low levels of these intact ORFs. In the lymph node, we found evidence that CTLA-4(+) cells contain lower levels of HIV-1 provirus compared to the other cell subsets. Importantly, however, we observed significant participant variation in the enrichment of HIV-1 proviruses with intact genomes or specific intact ORFs across these memory CD4(+) T-cell subsets, and therefore consideration of additional cellular markers will likely be needed to consistently identify cells harbouring latent, and potentially replication-competent, HIV-1. Frontiers Media S.A. 2023-01-26 /pmc/articles/PMC9909745/ /pubmed/36776833 http://dx.doi.org/10.3389/fimmu.2023.1064346 Text en Copyright © 2023 Fisher, Schlub, Boyer, Rasmussen, Rhodes, Hoh, Hecht, Deeks, Lewin and Palmer https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Fisher, Katie Schlub, Timothy E. Boyer, Zoe Rasmussen, Thomas A. Rhodes, Ajantha Hoh, Rebecca Hecht, Frederick M. Deeks, Steven G. Lewin, Sharon R. Palmer, Sarah Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4 |
title | Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4 |
title_full | Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4 |
title_fullStr | Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4 |
title_full_unstemmed | Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4 |
title_short | Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4 |
title_sort | unequal distribution of genetically-intact hiv-1 proviruses in cells expressing the immune checkpoint markers pd-1 and/or ctla-4 |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909745/ https://www.ncbi.nlm.nih.gov/pubmed/36776833 http://dx.doi.org/10.3389/fimmu.2023.1064346 |
work_keys_str_mv | AT fisherkatie unequaldistributionofgeneticallyintacthiv1provirusesincellsexpressingtheimmunecheckpointmarkerspd1andorctla4 AT schlubtimothye unequaldistributionofgeneticallyintacthiv1provirusesincellsexpressingtheimmunecheckpointmarkerspd1andorctla4 AT boyerzoe unequaldistributionofgeneticallyintacthiv1provirusesincellsexpressingtheimmunecheckpointmarkerspd1andorctla4 AT rasmussenthomasa unequaldistributionofgeneticallyintacthiv1provirusesincellsexpressingtheimmunecheckpointmarkerspd1andorctla4 AT rhodesajantha unequaldistributionofgeneticallyintacthiv1provirusesincellsexpressingtheimmunecheckpointmarkerspd1andorctla4 AT hohrebecca unequaldistributionofgeneticallyintacthiv1provirusesincellsexpressingtheimmunecheckpointmarkerspd1andorctla4 AT hechtfrederickm unequaldistributionofgeneticallyintacthiv1provirusesincellsexpressingtheimmunecheckpointmarkerspd1andorctla4 AT deekssteveng unequaldistributionofgeneticallyintacthiv1provirusesincellsexpressingtheimmunecheckpointmarkerspd1andorctla4 AT lewinsharonr unequaldistributionofgeneticallyintacthiv1provirusesincellsexpressingtheimmunecheckpointmarkerspd1andorctla4 AT palmersarah unequaldistributionofgeneticallyintacthiv1provirusesincellsexpressingtheimmunecheckpointmarkerspd1andorctla4 |